Business Description
Medeze Group PCL
ISIN : THC430010007
Description
Medeze Group PCL is engaged in the business of providing stem cell storage, analyzing, isolation, cultivation, and preservation services for medical use.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 21.76 | |||||
| Equity-to-Asset | 0.6 | |||||
| Debt-to-Equity | 0.02 | |||||
| Debt-to-EBITDA | 0.06 | |||||
| Interest Coverage | 20.14 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.45 | |||||
| Quick Ratio | 2.33 | |||||
| Cash Ratio | 1.92 | |||||
| Days Inventory | 71.58 | |||||
| Days Sales Outstanding | 35.2 | |||||
| Days Payable | 27.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.5 | |||||
| Operating Margin % | 43.88 | |||||
| Net Margin % | 36.12 | |||||
| FCF Margin % | 27.56 | |||||
| ROE % | 21.46 | |||||
| ROA % | 12.58 | |||||
| ROIC % | 16.42 | |||||
| ROC (Joel Greenblatt) % | 72.44 | |||||
| ROCE % | 18.58 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 75.74 | |||||
| PE Ratio without NRI | 75.74 | |||||
| PS Ratio | 27.25 | |||||
| PB Ratio | 15.21 | |||||
| Price-to-Tangible-Book | 15.37 | |||||
| Price-to-Free-Cash-Flow | 99.04 | |||||
| Price-to-Operating-Cash-Flow | 72.03 | |||||
| EV-to-EBIT | 57.69 | |||||
| EV-to-EBITDA | 54.17 | |||||
| EV-to-Revenue | 26.73 | |||||
| EV-to-FCF | 96.98 | |||||
| Price-to-Graham-Number | 7.2 | |||||
| Earnings Yield (Greenblatt) % | 1.73 | |||||
| FCF Yield % | 1.01 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medeze Group PCL Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 403.609 | ||
| EPS (TTM) (฿) | 0.136 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (฿) | 0 | ||
| 20-Day SMA (฿) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (฿) | 9.8 - 13.8 | ||
| Shares Outstanding (Mil) | 1,068 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medeze Group PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medeze Group PCL Stock Events
| Event | Date | Price(฿) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medeze Group PCL Frequently Asked Questions
What is Medeze Group PCL(BKK:MEDEZE)'s stock price today?
The current price of BKK:MEDEZE is ฿10.30. The 52 week high of BKK:MEDEZE is ฿13.80 and 52 week low is ฿9.80.
When is next earnings date of Medeze Group PCL(BKK:MEDEZE)?
The next earnings date of Medeze Group PCL(BKK:MEDEZE) is .
Does Medeze Group PCL(BKK:MEDEZE) pay dividends? If so, how much?
Medeze Group PCL(BKK:MEDEZE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers